Abstract
Objective To explore whether socio-economic, health and behavioural characteristics moderate effectiveness of a text message intervention with or without financial incentives versus a control group, and to examine differences in exploratory outcomes.
Methods Three-group randomized trial including 585 men with obesity comparing daily automated behavioural text messages for 12-months alongside financial incentives; text messages alone; or a waiting list control. Moderator analyses examined percent weight change after 12 months for 9 socio-economic and 11 health factors. Exploratory outcomes included: self-reported physical activity, sedentary behaviour, smoking and alcohol behaviours, engagement in 15 weight management strategies, and weight-management related confidence.
Results No moderator effects were found by any factors for either comparison versus control. There were no differences between groups for health behaviours. The texts with incentives group had higher levels of engagement in six strategies including weight goals, food changes and self-weighing, and higher levels of confidence compared to the control group.
Conclusion No evidence of differential intervention effectiveness was found across socio-economic, health or wellbeing status. The texts and financial incentives group showed greater engagement in weight management and favourable changes in weight management confidence compared to the control group.
Competing Interest Statement
Dr Hoddinott reported receiving grants from National Institute for Health Research (NIHR), and the Chief Scientist Office, Scotland, during the conduct of the study and serving as chair or member of Independent Trial Steering Committees unrelated to weight management trials; being a member of the NIHR School for Primary Care Research Funding panel. Dr Dombrowski reported receiving grants from the NIHR during the conduct of the study. Mr Swingler reported receiving grants from NIHR during the conduct of the study. Dr Cotton reported receiving grants from NIHR HTA (grant funding to institution) during the conduct of the study. Dr Avenell reported receiving grants from National Institute for Health and Care Research funding project in submission during the conduct of the study. Dr Hunt reported receiving grants from NIHR, the Australian Heart Foundation, and the Department of Health, Australia, during the conduct of the study; and serving as chair of the Health Improvement, Protection and Services Committee of the Chief Scientist Office. Dr MacLean reported receiving grants from the NIHR during the conduct of the study. Dr McKinley reported receiving grants from during the conduct of the study.Ms Torrens reported receiving grants from NIHR during the conduct of the study. Dr Turner reported receiving grants from NIHR during the conduct of the study and having had served as a member of the NIHR Health Technology Assessment (HTA) commissioning board, December 2017 to September 2020. Dr van der Pol reported receiving grants from NIHR Public Health Research and the Chief Scientist Office, Scotland, during the conduct of the study.Mr MacLennan reported receiving grants from the NIHR during the conduct of the study. No other disclosures were reported.
Clinical Trial
ISRCTN91974895
Funding Statement
This study was funded by grants from the NIHR
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North of Scotland Research Ethics Committee 2 gave ethical approval for this work [20/NS/0141]
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
